6CQ Stock Overview
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Cresco Labs Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.79 |
| 52 Week High | CA$2.60 |
| 52 Week Low | CA$0.89 |
| Beta | 2.07 |
| 1 Month Change | -5.19% |
| 3 Month Change | -3.24% |
| 1 Year Change | 29.24% |
| 3 Year Change | -83.32% |
| 5 Year Change | n/a |
| Change since IPO | -73.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6CQ | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -8.3% | 3.9% | 2.0% |
| 1Y | 29.2% | -28.2% | 2.0% |
Return vs Industry: 6CQ exceeded the German Pharmaceuticals industry which returned -28.6% over the past year.
Return vs Market: 6CQ exceeded the German Market which returned 1.3% over the past year.
Price Volatility
| 6CQ volatility | |
|---|---|
| 6CQ Average Weekly Movement | 13.1% |
| Pharmaceuticals Industry Average Movement | 6.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 6CQ's share price has been volatile over the past 3 months.
Volatility Over Time: 6CQ's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 2,760 | Charlie Bachtell | www.crescolabs.com |
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy’s Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts.
Cresco Labs Inc. Fundamentals Summary
| 6CQ fundamental statistics | |
|---|---|
| Market cap | €808.60m |
| Earnings (TTM) | -€164.08m |
| Revenue (TTM) | €706.76m |
0.9x
P/S Ratio-4.1x
P/E RatioIs 6CQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6CQ income statement (TTM) | |
|---|---|
| Revenue | US$756.06m |
| Cost of Revenue | US$393.69m |
| Gross Profit | US$362.37m |
| Other Expenses | US$537.89m |
| Earnings | -US$175.52m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 47.93% |
| Net Profit Margin | -23.22% |
| Debt/Equity Ratio | 96.2% |
How did 6CQ perform over the long term?
See historical performance and comparison